Security · CUSIP 14875P107
CATABASIS PHARMACEUTICALS IN
COM · institutional ownership from 13F filings
13F holders
1
Shares held
285.8K
Value held
$1.2M
New / sold out
0 / 27
Added / reduced
0 / 1
net -21.0M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2018
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| SV Health Investors, LLC | 285,765 | $1.2M | 0.77% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| FEDERATED INVESTORS INC /PA/ | Sold out | -10,434,000 | -100.0% |
| SV Health Investors, LLC | Reduced | -2,571,902 | -90.0% |
| Vanguard Group Inc | Sold out | -2,494,827 | -100.0% |
| Stonepine Capital Management, LLC | Sold out | -2,166,154 | -100.0% |
| CVI Holdings, LLC | Sold out | -730,320 | -100.0% |
| OPPENHEIMER & CO INC | Sold out | -508,415 | -100.0% |
| DEUTSCHE BANK AG\ | Sold out | -505,702 | -100.0% |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -453,740 | -100.0% |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -290,471 | -100.0% |
| BlackRock Inc. | Sold out | -170,293 | -100.0% |
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.